Publications by authors named "Tobias Lotts"

Claim this Profile
N
Non-Neuronal Kappa Opioid Pathway Profiling in the Skin of Different Chronic Pruritus-Associated Dermatoses.
Henning Wiegmann, Sonja Ständer, Svetlana Bobko, Lina Renkhold, Tobias Lotts

J Invest Dermatol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isatis tinctoria L.-derived Petroleum Ether Extract Mediates Anti-inflammatory Effects via Inhibition of Interleukin-6, Interleukin-33 and Mast Cell Degranulation.
Tobias Lotts, Kathrin Kabrodt, Johanna Hummel, Dorit Binder, Ingo Schellenberg

Acta Derm Venereol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral Sensitization and Loss of Descending Inhibition Is a Hallmark of Chronic Pruritus.
Esther M Pogatzki-Zahn, Manuel P Pereira, Alexander Cremer, Claudia Zeidler, Tim Dreyer, Tobias Lotts

J Invest Dermatol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensory Qualities Point to Different Structural and Functional Skin Patterns in Chronic Pruritus Patients. A Translational Explorative Study.
Johanna Hidding, Konstantin Agelopoulos, Manuel P Pereira, Heike Conrad, Hanns Hatt, Tobias Lotts

Acta Derm Venereol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydroavenanthramide D inhibits mast cell degranulation and exhibits anti-inflammatory effects through the activation of neurokinin-1 receptor.
Tobias Lotts, Konstantin Agelopoulos, Ngoc Q Phan, Karin Loser, Gerhard Schmaus

Exp Dermatol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Synthesis of Enantiomerically Pure Decahydroquinoxalines as Potent and Selective κ-Opioid Receptor Agonists with Anti-Inflammatory Activity in Vivo.
Michael Soeberdt, Peter Molenveld, Roy P M Storcken, Renaud Bouzanne des Mazery, Geert Jan Sterk, Tobias Lotts

J Med Chem· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical nalfurafine exhibits anti-inflammatory and anti-pruritic effects in a murine model of AD.
Graham Elliott, Raymond Vanwersch, Michael Soeberdt, Dieter Metze, Tobias Lotts

J Dermatol Sci· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Facing the challenges of chronic pruritus: a report from a multi-disciplinary medical itch centre in Germany.
Sonja Ständer, Esther Pogatzki-Zahn, Astrid Stumpf, Fleur Fritz, Bettina Pfleiderer, Tobias Lotts

Acta Derm Venereol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the antipruritic effects of topical pimecrolimus in non-atopic prurigo nodularis: results of a randomized, hydrocortisone-controlled, double-blind phase II trial.
Dorothee Siepmann, Tobias Lotts, Christine Blome, Matthias Braeutigam, Ngoc Quan Phan

Dermatology· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research in practice: substance P antagonism in chronic pruritus.
Tobias Lotts, Sonja Ständer

J Dtsch Dermatol Ges· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigational drugs for pruritus.
Heike Benecke, Tobias Lotts, Sonja Ständer

Expert Opin Investig Drugs· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review.
Ngoc Quan Phan, Tobias Lotts, Attila Antal, Jeffrey D Bernhard, Sonja Ständer

Acta Derm Venereol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis